Biogen, Bio-Thera Shake Hands On US Actemra Settlement
Roche Sued Biosimilar Sponsors In July; Originator Braces For 2024 US Competition
Biogen, Bio-Thera Solutions and Roche have announced a settlement has been reached allowing patent-infringement litigation over Actemra to be dismissed.
